References

Bacteriophages as a modern diagnostic tool: Innovations, applications and challenges

10.1007/s11033-025-10967-5 · 2025 · External reference

The role of innate immunity, antibiotics, and bacteriophages in the course of bacterial infections and their treatment

10.1073/pnas.2507914122 · 2025 · External reference

Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches

10.1172/jci187996 · 2025 · External reference

Rising antimicrobial resistance: Impending post-antibiotic era

10.1016/j.mjafi.2024.07.008 · 2025 · External reference

Emerging therapeutic strategies to combat antimicrobial resistance in the post-antibiotic era

10.1002/jobm.70070 · 2025 · External reference

Combating Klebsiella pneumoniae: From antimicrobial resistance mechanisms to phage-based combination therapies

10.3389/fcimb.2025.1691215 · 2025 · External reference

Engineering phages to fight multidrug-resistant bacteria

10.1021/acs.chemrev.4c00681 · 2025 · External reference

Recent advances in phage defense systems and potential overcoming strategies

10.1016/j.biotechadv.2023.108152 · 2023 · External reference

Phage-encoded endolysins

10.3390/antibiotics10020124 · 2021 · External reference

Microbiome-phage interactions in inflammatory bowel disease

10.1016/j.cmi.2022.08.027 · 2023 · External reference

Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation

10.1016/j.cell.2022.07.003 · 2022 · External reference

An enterococcal phage-derived enzyme suppresses graft-versus-host disease

10.1038/s41586-024-07667-8 · 2024 · External reference

The gut microbiota in cancer immunity and immunotherapy

10.1038/s41423-025-01326-2 · 2025 · External reference

Gut microbiota and epigenetic inheritance: implications for the development of IBD

10.1080/19490976.2025.2490207 · 2025 · External reference

Gut commensal Bifidobacterium-derived extracellular vesicles modulate the therapeutic effects of anti-PD-1 in lung cancer

10.1038/s41467-025-58553-4 · 2025 · External reference

The gut-brain axis in Alzheimer’s disease is shaped by commensal gut microbiota derived extracellular vesicles

10.1080/19490976.2025.2501193 · 2025 · External reference

An early history of phage therapy in the United States: Is it time to reconsider

10.3121/cmr.2021.1605 · 2021 · External reference

Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant acinetobacter baumannii infection

10.1128/aac.00954-17 · 2017 · External reference

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus

10.1038/s41591-019-0437-z · 2019 · External reference

Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): The randomised, open-label, first part of a two-part phase 2 trial

10.1016/s1473-3099(24)00424-9 · 2024 · External reference

Study on early historical literature of chinese phage (in Chinese)

2023 · External reference

Heterogeneous Klebsiella pneumoniae co-infections complicate personalized bacteriophage therapy

10.3389/fcimb.2020.608402 · 2021 · External reference

Exploration of the feasibility of clinical application of phage treatment for multidrug-resistant Serratia marcescens-induced pulmonary infection

10.1080/22221751.2025.2451048 · 2025 · External reference

Personalized bacteriophage therapy for chronic biliary tract Pseudomonas aeruginosa infections

10.1016/j.hlife.2025.03.004 · 2025 · External reference

Consensus on standards of phage quality for prophylactic and therapeutic use (in Chinese)

2024 · External reference

Gut virome and its implications in the pathogenesis and therapeutics of inflammatory bowel disease

10.1186/s12916-025-04016-y · 2025 · External reference

Faecal phageome transplantation alleviates intermittent intestinal inflammation in IBD and the timing of transplantation matters: a preclinical proof-of-concept study in mice

10.1136/gutjnl-2024-333598 · 2025 · External reference

Gut microbiome: Temperate and latent phages are dominant in the human gut

10.1016/j.cub.2025.01.006 · 2025 · External reference

High-throughput single-microbe RNA sequencing reveals adaptive state heterogeneity and host-phage activity associations in human gut microbiome

10.1093/procel/pwae027 · 2025 · External reference

Effects of bacteriophages on gut microbiome functionality

10.1080/19490976.2025.2481178 · 2025 · External reference

Gut microbiome ADP-ribosyltransferases are widespread phage-encoded fitness factors

10.1016/j.chom.2021.07.011 · 2021 · External reference

Murine colitis reveals a disease-associated bacteriophage community

10.1038/s41564-018-0210-y · 2018 · External reference

Dietary whey protein protects against Crohn’s disease by orchestrating cross-kingdom interaction between the gut phageome and bacteriome

10.1136/gutjnl-2024-334516 · 2025 · External reference

Isolation, engineering and ecology of temperate phages from the human gut

10.1038/s41586-025-09614-7 · 2025 · External reference

The gut virome in association with the bacteriome in gastrointestinal diseases and beyond: roles, mechanisms, and clinical applications

10.1093/pcmedi/pbaf010 · 2025 · External reference

The mef(A)/msr(D)-carrying streptococcal prophage Φ1207.3 encodes an SOS-like system, induced by UV-C light, responsible for increased survival and increased mutation rate

10.1128/jb.00191-23 · 2023 · External reference

Antibiotic-mediated prophage activation: Mechanisms, consequences, and therapeutic implications

10.1016/j.ijantimicag.2025.107655 · 2026 · External reference

Interactions between bacterial and phage communities in natural environments

10.1038/s41579-021-00602-y · 2022 · External reference

Large-scale analysis of bacterial genomes reveals thousands of lytic phages

10.1038/s41564-025-02203-4 · 2026 · External reference

Evolutionary selection of trimethoprim-resistant dfrA genes in lytic phages affects phage and host fitness during infection

10.4028/b-xdtcg5 · 2025 · External reference

Long-read metagenomics reveals phage dynamics in the human gut microbiome

10.1038/s41586-025-09786-2 · 2026 · External reference

Bacteriophage-host interactions and the therapeutic potential of bacteriophages

10.3390/v16030478 · 2024 · External reference

Capsules and their traits shape phage susceptibility and plasmid conjugation efficiency

10.1038/s41467-024-46147-5 · 2024 · External reference

Phage tailspike modularity and horizontal gene transfer reveals specificity towards E. coli O-antigen serogroups

10.1186/s12985-023-02138-4 · 2023 · External reference

Characterization and host range prediction of Staphylococcus aureus phages through receptor-binding protein analysis

10.1016/j.celrep.2025.115369 · 2025 · External reference

Prediction of Klebsiella phage-host specificity at the strain level

10.1038/s41467-024-48675-6 · 2024 · External reference

Bacteria- and phage-derived proteins in phage infection

10.31083/fbl24478 · 2025 · External reference

Identifying components of the Shewanella phage LambdaSo lysis system

10.1128/jb.00022-24 · 2024 · External reference

Endolysin regulation in phage Mu lysis

10.1128/mbio.00813-22 · 2022 · External reference

Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice

10.1038/s41587-023-01759-y · 2024 · External reference

Targeting Pseudomonas aeruginosa biofilm with an evolutionary trained bacteriophage cocktail exploiting phage resistance trade-offs

10.1038/s41467-024-52595-w · 2024 · External reference

Engineering phage host-range and suppressing bacterial resistance through phage tail fiber mutagenesis

10.1016/j.cell.2019.09.015 · 2019 · External reference

Bacteriophage-derived endolysins as innovative antimicrobials against bovine mastitis-causing streptococci and staphylococci: A state-of-the-art review

10.1186/s13028-024-00740-2 · 2024 · External reference

Bacteriophage protein Gp46 is a cross-species inhibitor of nucleoid-associated HU proteins

2022 · External reference

Cinnamic-hydroxamic-acid derivatives exhibit antibiotic, anti-biofilm, and supercoiling relaxation properties by targeting bacterial nucleoid-associated protein HU

2026 · External reference

Phage tailspike protein coated gold nanoparticles combined with smartphone for rapid bacterial detection and photothermal sterilization

10.1016/j.talanta.2024.126268 · 2024 · External reference

Precise photothermal treatment of methicillin-resistant S. aureus infection via phage lysin-cell binding domain-modified gold nanosheets

10.1021/acsami.2c20102 · 2023 · External reference

The gut virome: A new microbiome component in health and disease

10.1016/j.ebiom.2022.104113 · 2022 · External reference

Urbanization and the gut microbiota in health and inflammatory bowel disease

10.1038/s41575-018-0003-z · 2018 · External reference

Inflammatory bowel disease presentation and diagnosis

10.1016/j.suc.2019.08.001 · 2019 · External reference

Host-microbiota interactions in inflammatory bowel disease

10.1038/s41577-019-0268-7 · 2020 · External reference

Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease

10.1016/j.chom.2019.10.009 · 2019 · External reference

The gut virome in inflammatory bowel diseases

10.1016/j.coviro.2021.10.005 · 2021 · External reference

Disease-specific alterations in the enteric virome in inflammatory bowel disease

10.1016/j.cell.2015.01.002 · 2015 · External reference

Phages infecting Faecalibacterium prausnitzii belong to novel viral genera that help to decipher intestinal viromes

10.1186/s40168-018-0452-1 · 2018 · External reference

Gut mucosal virome alterations in ulcerative colitis

10.1136/gutjnl-2018-318131 · 2019 · External reference

Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis

10.1016/j.chom.2019.01.008 · 2019 · External reference

The gut ileal mucosal virome is disturbed in patients with Crohn’s disease and exacerbates intestinal inflammation in mice

10.1038/s41467-024-45794-y · 2024 · External reference

Bacteriophages targeting adherent invasive escherichia coli strains as a promising new treatment for Crohn’s disease

2017 · External reference

Sustained in situ protein production and release in the mammalian gut by an engineered bacteriophage

10.1038/s41587-025-02570-7 · 2026 · External reference

Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome

10.1136/gutjnl-2017-313952 · 2018 · External reference

Clostridioides difficile phage biology and application

10.1093/femsre/fuab012 · 2021 · External reference

Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy

10.1038/s41551-019-0423-2 · 2019 · External reference

In Vivo Targeting of clostridioides difficile using phage-delivered CRISPR-Cas3 antimicrobials

10.1128/mbio.00019-20 · 2020 · External reference

The gut-liver axis in liver disease: Pathophysiological basis for therapy

10.1016/j.jhep.2019.10.003 · 2020 · External reference

Intestinal virome in patients with alcoholic hepatitis

10.1002/hep.31459 · 2020 · External reference

Intestinal virome signature associated with severity of nonalcoholic fatty liver disease

10.1053/j.gastro.2020.07.005 · 2020 · External reference

Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy

10.1136/gutjnl-2020-322470 · 2021 · External reference

Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease

10.1038/s41586-019-1742-x · 2019 · External reference

Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae

10.1038/s41467-023-39028-w · 2023 · External reference

Metagenomic analyses of multiple gut datasets revealed the association of phage signatures in colorectal cancer

10.3389/fcimb.2022.918010 · 2022 · External reference

Expanding the colorectal cancer biomarkers based on the human gut phageome

10.1128/spectrum.00090-21 · 2021 · External reference

The roles of the virome in cancer

10.3390/microorganisms9122538 · 2021 · External reference

Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8+ T cell effector functions

10.1016/j.immuni.2024.02.014 · 2024 · External reference

Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity

10.1016/j.chom.2025.05.004 · 2025 · External reference

Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer

10.1126/sciadv.aba1590 · 2020 · External reference

Phage engineering and phage-assisted CRISPR-Cas delivery to combat multidrug-resistant pathogens

2022 · External reference

Engineered phage-based cancer vaccines: current advances and future directions

10.3390/vaccines11050919 · 2023 · External reference

Tumor-targeted delivery of PD-1-displaying bacteriophages by escherichia coli for adjuvant treatment of colorectal cancer

10.1021/acssynbio.4c00570 · 2025 · External reference

A DNA nanopatch-bacteriophage system targeting streptococcus gallolyticus for inflammatory bowel disease treatment and colorectal cancer prevention

10.1002/adma.202513718 · 2025 · External reference

Decoding the human phageome helps to unravel microbial dynamics in health and disease

10.1128/aem.00919-25 · 2025 · External reference

Bacteriophages and their potential for treatment of gastrointestinal diseases

10.1038/s41575-021-00536-z · 2022 · External reference

Shotgun metagenomics of gastric biopsies reveals compositional and functional microbiome shifts in high- and low-gastric-cancer-risk populations from Colombia, South America

10.1080/19490976.2023.2186677 · 2023 · External reference

Causal associations between gut microbiota and urological tumors: a two-sample mendelian randomization study

10.1186/s12885-023-11383-3 · 2023 · External reference

Microbiome-urothelium crosstalk in bladder cancer: From dysbiosis to clinical translation

10.1002/imo2.70081 · 2026 · External reference

Insights into the interplay between the urinary microbiome and bladder cancer: A comprehensive review

10.3390/jcm13164927 · 2024 · External reference

Cross-kingdom microbiome interactions along the gut-lung axis: Immune-microecological coordination, shared mechanisms, and disease-context dependence in respiratory disorders

10.1080/19490976.2026.2689168 · 2026 · External reference

Phage therapy in oncology: opportunities for cancer prevention and treatment

10.1016/j.molmed.2026.02.001 · 2026 · External reference

Gut virome plays an extended role with bacteriome in neurological health and disease

10.1016/j.jns.2026.125754 · 2026 · External reference

A metagenomic study of gut viral markers in amyloid-positive Alzheimer’s disease patients

10.1186/s13195-023-01285-8 · 2023 · External reference

Alterations of the gut virome in patients with Parkinson’s disease

10.1093/gerona/glag001 · 2026 · External reference

Children with autism show differences in the gut DNA virome compared to non-autistic children: a case control study

10.1186/s12887-023-03981-8 · 2023 · External reference

Alterations in fecal virome and bacteriome virome interplay in children with autism spectrum disorder

2024 · External reference

Implications of oral streptococcal bacteriophages in autism spectrum disorder

10.1038/s41522-022-00355-3 · 2022 · External reference

Viewing Psychiatric Disorders Through Viruses: Simple Architecture, Burgeoning Implications

10.1007/s12264-025-01443-y · 2025 · External reference

Metagenomic sequencing indicates that the oropharyngeal phageome of individuals with schizophrenia differs from that of controls

10.1093/schbul/sbu197 · 2015 · External reference

Unveiling the human brain virome in brodmann area 46: Novel insights into dysbiosis and its association with schizophrenia

10.1093/schizbullopen/sgad029 · 2023 · External reference

Alterations in fecal bacteriome virome interplay and microbiota-derived dysfunction in patients with schizophrenia

10.1038/s41398-025-03239-0 · 2025 · External reference

Metagenome-based characterization of the gut virome in patients with schizophrenia

10.1186/s12967-025-06923-3 · 2025 · External reference

A phage displaying an Aβ-interacting peptide mitigates neurotoxicity and prevents Aβ-driven gene expression changes

10.3389/fnmol.2025.1716626 · 2025 · External reference

Phage display derived peptides for Alzheimer’s disease therapy and diagnosis

10.7150/thno.68636 · 2022 · External reference

Bacteriophages targeting Enterococcus faecalis enhance the therapeutic efficacy of levodopa in an MPTP-induced Parkinson’s disease mouse model with E. faecalis gut colonization

10.1038/s41598-024-77038-w · 2024 · External reference

Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: An open-label study

10.1186/s40168-016-0225-7 · 2017 · External reference

Alterations in the gut virome in obesity and type 2 diabetes mellitus

10.1053/j.gastro.2021.06.056 · 2021 · External reference

Spatial disturbances in altered mucosal and luminal gut viromes of diet-induced obese mice

10.1111/1462-2920.13182 · 2016 · External reference

Fecal viral community responses to high-fat diet in mice

10.1128/msphere.00833-19 · 2020 · External reference

Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children

10.1073/pnas.1706359114 · 2017 · External reference

A human gut phage catalog correlates the gut phageome with type 2 diabetes

10.1186/s40168-018-0410-y · 2018 · External reference

Enteric phageome alterations in patients with type 2 diabetes

2020 · External reference

Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model

10.1136/gutjnl-2019-320005 · 2020 · External reference

Prediction of strain level phage-host interactions across the Escherichia genus using only genomic information

10.1038/s41564-024-01832-5 · 2024 · External reference

Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection

10.1016/j.cell.2022.04.024 · 2022 · External reference

All the world’s a phage

10.1073/pnas.2523344122 · 2025 · External reference

Temperate bacteriophage SapYZUs7 alters Staphylococcus aureus fitness balance by regulating expression of phage resistance, virulence and antimicrobial resistance gene

10.1016/j.micres.2024.128040 · 2025 · External reference

Phage-plasmids spread antibiotic resistance genes through infection and lysogenic conversion

10.1128/mbio.01851-22 · 2022 · External reference

Phage therapy: Combating evolution of bacterial resistance to phages

10.3390/v17081094 · 2025 · External reference

Phage resistance bidirectionally altered antibiotic susceptibility in Klebsiella pneumoniae via galE mutation

10.1016/j.ijantimicag.2026.107738 · 2026 · External reference

Fitness costs of phage-driven resistance mutations in Salmonella Enteritidis populations

10.1128/jvi.01950-25 · 2026 · External reference

Cross-reactive anti-prophage antibodies and bacterial heteroresistance implicated in phage therapeutic failure

10.1038/s41591-026-04301-0 · 2026 · External reference

Antibacterial efficacy of a K5-specific Klebsiella phage in milk and investigation of phage resistance mechanisms

10.3168/jds.2024-26089 · 2025 · External reference

Overcoming phage resistance: Efficacy of sequential phage-colistin therapy against carbapenem-resistant Acinetobacter baumannii

2025 · External reference

Individual bacteria in structured environments rely on phenotypic resistance to phage

10.1371/journal.pbio.3001406 · 2021 · External reference

In vitro and in vivo selection and cost of bacteriophage resistance on natural Escherichia coli

10.1093/femsml/uqaf017 · 2025 · External reference

PHEIGES: All-cell-free phage synthesis and selection from engineered genomes

10.1038/s41467-024-46585-1 · 2024 · External reference

Cross-genus rebooting of custom-made, synthetic bacteriophage genomes in L-form bacteria

10.1073/pnas.1714658115 · 2018 · External reference

Exploring functional insights into the human gut microbiome via the structural proteome

10.1016/j.chom.2025.11.001 · 2026 · External reference